Emoxypine was first synthesized in Russia and has been primarily used in former Soviet states for its purported anti-oxidant, anxiolytic, anti-stress, anti-alcohol, anticonvulsant, nootropic, neuroprotective, and anti-inflammatory effects.
It is also believed to improve cerebral blood circulation, inhibit thrombocyte aggregation, lower cholesterol, and exhibit cardioprotective and antiatherosclerotic actions. Emoxypine’s mechanism of action is thought to involve antioxidant and membrane-protective effects, though these remain unverified in comprehensive reviews.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | mexidol, 2-Ethyl-6-methylpyridin-3-ol succinate, 2-Ethyl-3-hydroxy-6-methylpyridine Succinate |
|---|---|
| IUPAC Name | butanedioic acid;2-ethyl-6-methylpyridin-3-ol |
| CAS | 127464-43-1 |
| Molecular Weight | 255.27 |
| Molecular Formula | C12H17NO5 |
| SMILES | CCC1=C(C=CC(=N1)C)O.C(CC(=O)O)C(=O)O |